New classification system-based visual outcome in Eales' disease

Saxena, Sandeep; Kumar, Dipak
July 2007
Indian Journal of Ophthalmology;Jul2007, Vol. 55 Issue 4, p267
Academic Journal
journal article
Purpose: A retrospective tertiary care center-based study was undertaken to evaluate the visual outcome in Eales' disease, based on a new classification system, for the first time.Materials and Methods: One hundred and fifty-nine consecutive cases of Eales' disease were included. All the eyes were staged according to the new classification: Stage 1: periphlebitis of small (1a) and large (1b) caliber vessels with superficial retinal hemorrhages; Stage 2a: capillary non-perfusion, 2b: neovascularization elsewhere/of the disc; Stage 3a: fibrovascular proliferation, 3b: vitreous hemorrhage; Stage 4a: traction/combined rhegmatogenous retinal detachment and 4b: rubeosis iridis, neovascular glaucoma, complicated cataract and optic atrophy. Visual acuity was graded as: Grade I 20/20 or better; Grade II 20/30 to 20/40; Grade III 20/60 to 20/120 and Grade IV 20/200 or worse. All the cases were managed by medical therapy, photocoagulation and/or vitreoretinal surgery. Visual acuity was converted into decimal scale, denoting 20/20=1 and 20/800=0.01. Paired t-test / Wilcoxon signed-rank tests were used for statistical analysis.Results: Vitreous hemorrhage was the commonest presenting feature (49.32%). Cases with Stages 1 to 3 and 4a and 4b achieved final visual acuity ranging from 20/15 to 20/40; 20/80 to 20/400 and 20/200 to 20/400, respectively. Statistically significant improvement in visual acuities was observed in all the stages of the disease except Stages 1a and 4b.Conclusion: Significant improvement in visual acuities was observed in the majority of stages of Eales' disease following treatment. This study adds further to the little available evidences of treatment effects in literature and may have effect on patient care and health policy in Eales' disease.


Related Articles

  • Tratamiento de las vasculitis sistémicas asociadas a ANCA. Fernández de Larrinoa, Iñigo Rúa-Figueroa; Arruabarrena, Celia Erausquin // Reumatologia Clinica;may/jun2010, Vol. 6 Issue 3, p161 

    The treatment of systemic vasculitis has undergone important changes in recent years. Cyclophosphamide still plays a crucial role in the induction of remission in severe forms, reducing the mortality. However, its use entails a significant long-term toxicity and the accumulation of damage...

  • Methotrexate.  // Reactions Weekly;11/10/2007, Issue 1177, p18 

    The article describes the cases of three children who developed glioblastoma during treatment with prophylactic cranial irradiation and methotrexate for acute lymphoblastic leukemia. All the children, a 4-year-old girl, a 6-year-old boy and a 10-year-old boy had received intrathecal...

  • Benefit of intravenous immunoglobulin in a patient with longstanding polymyositis/systemic sclerosis overlap syndrome. Abelha-Aleixo, J.; Bernardo, A.; Costa, L. // Acta Reumatológica Portuguesa;abr-jun2015, Vol. 40 Issue 2, p176 

    The authors describe the case of a 49-year-old female with a progressive tetraparesis with two years of evolution, whose diagnostic study revealed a polymyositis/systemic sclerosis overlap syndrome. The patient was completely dependent and bedridden and had pulmonary, gastrointestinal, skin and...

  • Crohn's disease: current treatment options. Akobeng, A. K. // Archives of Disease in Childhood;Sep2008, Vol. 93 Issue 9, p787 

    There is no known cure for Crohn's disease (CD), but a better understanding of the evidence base of both established treatments (such as enteral nutrition, corticosteroids, 5-aminosalicylates and immunosuppressive agents) and emerging treatments (such as the anti-tumour necrosis factor-α...

  • Immunosuppressants.  // Reactions Weekly;May2015, Vol. 1550 Issue 1, p119 

    The article presents a case study of a 8.5-year-old boy who was diagnosed with Fusarium solani ecthyma gangrenosum during treatment with several immunosuppressants such as ciclosporin, methotrexate, and prednisolone, published in a 2013 issue of the journal "Mikologia Lekarska." Topics discussed...

  • Bilateral episcleritis followed by right optic perineuritis with severe visual loss: a case report. Nishijima, Haruo; Suzuki, Chieko; Tomiyama, Masahiko // Neurological Sciences;Nov2015, Vol. 36 Issue 11, p2139 

    No abstract available.

  • A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate. Izumi Kurata; Hiroto Tsuboi; Hidenori Takahashi; Mizuki Yagishita; Saori Abe; Hiroshi Ebe; Hiroyuki Takahashi; Hiromitsu Asashima; Tomoya Hirota; Shinya Hagiwara; Naoto Umeda; Yuya Kondo; Hiroshi Ogishima; Takeshi Suzuki; Isao Matsumoto; Takayuki Sumida // Rheumatology;Jul2015, Vol. 54 Issue 7, p1160 

    The article presents a clinical vignette of a 45-year-old woman diagnosed with relapsing neurosarcoidosis with brain nodules and hydrocephalus. Biopsy revealed non-caseating epithelioid cell granuloma, while brain magnetic resonance imaging (MRI) showed multiple high-intensity foci on the...

  • FACTORES CLÍNICOS PREDITIVOS DE COMPLICAÇÕES NA DOENÇA DE CROHN. CERQUEIRA, Rute M.; LAGO, Paula // Acta Medica Portuguesa;SUP2011, Vol. 24 Issue S4, p1057 

    Crohn's disease (CD) is a progressive disease that is subdivided in three phenotypes: inflammatory, stricturing, and penetrating. At diagnosis most CD patients have inflammatory disease. However, the natural history of CD evolves over time to structural digestive tract complications (strictures...

  • Management, clinical outcomes, and complications of acute cannula-related peripheral vein phlebitis of the upper extremity: A retrospective study. Dunda, S. E.; Demir, E.; Mefful, O. J.; Grieb, G.; Bozkurt, A.; Pallua, N. // Phlebology;Jul2015, Vol. 30 Issue 6, p381 

    Objective: Acute phlebitis due to peripheral vein catheter use is frequently observed in clinical practice, and requires surgical therapy in severe cases. In this retrospective study, we aimed to increase awareness, evaluate current treatment options, and develop recommendations to optimize...

  • Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis. Alberici, Federico; Smith, Rona M.; Jones, Rachel B.; Roberts, Darren M.; Willcocks, Lisa C.; Chaudhry, Afzal; Smith, Kenneth G. C.; Jayne, David R. W. // Rheumatology;Jul2015, Vol. 54 Issue 7, p1153 

    Objective. ANCA-associated vasculitis (AAV) is characterized by a chronic relapsing course. Rituximab (RTX) is an effective maintenance treatment; however, the long-term outcomes after its discontinuation are unclear. The aim of this study was to explore the long-term outcomes of AAV patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics